Leading cryogenic and mechanical freezing equipment company CES Group is strengthening its dedication to the pharmaceutical and biotech industries, with the news that it is welcoming a new CES Pharma Systems division.
The new division is specialised in providing cryogenic equipment to the developments at CES and reinforces the group's services to the pharmaceutical and biotech industries, through continued design & manufacture of quality freezing and flexible solutions.
The CES equipment line offers key advantages for product stabilisation of sensitive materials, while ensuring the product quality remains intact, and includes blast freezing, pelletising, freeze & thaw, and flash freezing.
With extensive technical expertise in the field of cryogenic treatment processes, the CES Group has contributed to the development of numerous technical innovations & patented technologies throughout the past 20 years.
The company's equipment, using liquid nitrogen, offers key advantages for product stabilisation of sensitive materials and this, in combination with versatility and expertise, enables CES to meet today's stringent requirements.
Such capabilities have captured the attention of the pharmaceutical & biotech industries and have led to the conception of a new name & a new brochure to address this clearly - enter the new CES Pharma Systems division.